UK markets closed

Sanofi (SAN.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
86.72+0.12 (+0.14%)
At close: 5:35PM CEST
Full screen
Previous close86.60
Open86.85
Bid0.00 x 0
Ask0.00 x 0
Day's range86.36 - 86.96
52-week range74.92 - 95.82
Volume1,419,341
Avg. volume1,977,892
Market cap108.311B
Beta (5Y monthly)0.40
PE ratio (TTM)8.96
EPS (TTM)9.68
Earnings date29 Jul 2021
Forward dividend & yield3.20 (3.70%)
Ex-dividend date05 May 2021
1y target est82.62
  • Editor's pick
    Yahoo Finance Video

    People choosing to ditch their masks will be a ‘gradual process’: Doctor

    Dr. Alice Chen, General Internist in Washington, D.C. & Former Executive Director with Doctors for America, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus pandemic.

  • Yahoo Finance Video

    CDC approves those fully vaccinated to largely ditch masks indoors

    Yahoo Finance’s Anjalee Khemlani reports the latest updates on the coronavirus.

  • Is Sanofi a Good Buy in 2021?
    Motley Fool

    Is Sanofi a Good Buy in 2021?

    The French-based pharmaceutical company Sanofi (NASDAQ: SNY) has been flying under the radar over the past few years as companies like AbbVie, Bristol Myers Squibb, and Merck have dominated the space through the tremendous success of their drugs. Sanofi was actually a creation of several different companies, including Aventis, Synthélabo, Hoechst, Rhône-Poulenc Rorer, and several others. Through mergers and acquisitions (M&A) we got the Sanofi we know today.